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Summary
Objective To assess secondary preventative therapy among
postmenopausal female inpatients (aged 75 years and over) receiving
surgical management for a fractured neck of femur using two service
delivery models.
Design Practice in two fracture units was audited and compared using
the NICE guidelines (TA 87) as an audit standard.
Setting Two fracture units: one with a fracture liaison service and one
without.
Participants Postmenopausal female inpatients (aged 75 years and
over) receiving surgical management for a fractured neck of femur.
Main outcome measures Rate of anti-resorptive treatment and
rate of enquiry into risk factors.
Results There was a signiﬁcantly higher rate of anti-resorptive
treatment (90.5% compared to 60.9% with a difference of 29.6%, p <0.001)
and enquiry into risk factors (83% compared to 7%) in the unit with a
fracture liaison service.
Conclusions We propose that a hospital-based enhanced fracture
liaison service may result in higher osteoporosis treatment rates among
postmenopausal hospitalized hip fracture patients aged 75 years and over.
Introduction
The care of osteoporotic fractures presents a sig-
niﬁcant challenge to healthcare systems and to
society in general. Postmenopausal women are a
group at high risk of osteoporosis. In the UK
approximately 200,000 patients sustain a fragility
fracture each year, a ﬁgure which is predicted to
rise further as the population continues to age.
1
A signiﬁcant proportion of this group (up to
50%) do not return to their pre-morbid level of
mobility,
2 with healthcare costs in the UK totalling
£1.8 billion annually
3 and £12,163 for the acute
surgical episode following a fractured neck of
femur.
4 These are serious fractures with associated
mortality of 10% within 1 month and 33% within 1
year of a neck of femur (hip) fracture.
5
The beneﬁts of secondary preventative therapy
with bisphosphonates are known with a reduction
in fracture incidence of up to 50%,
6 and a more
recent study also noted a reduction in mortality
of 28% among patients receiving an intravenous
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1bisphosphonate infusion following neck of femur
fracture.
7 Currently assessment rates for second-
ary prevention of osteoporosis are low,
8–10 with
a substantial gap existing between known
evidence-based therapy and clinical practice. A
range of models exists with the aim of optimizing
secondary preventative treatment.
In this report we compare assessment and treat-
ment rates in two fracture units utilizing different
models of service delivery.
Methods
Our aim was to compare and contrast practice in
two fracture units in Northern Ireland in order
to assess the effects of an enhanced fracture
liaison service. Both units have similar population
demographics with regard to age, social class and
fracture incidence.
Site A is a district general hospital providing
treatment in a 36-bed Trauma and Orthopaedic
Unit, with no formal policy for the secondary pre-
vention of osteoporosis currently in existence.
Patients are admitted to the trauma unit via
A&E. Care is provided by trauma department
doctors and a staff-grade orthogeriatrician (3.5
days per week) who will provide a medical assess-
ment of a signiﬁcant proportion of the unit’s inpa-
tients. Consultant geriatrician ward-level
assessment is available on a referral basis.
Site B is a tertiary referral trauma centre (com-
prising 95 beds) which utilizes a continuous
acute orthogeriatric care model for ward patients
(one associate specialist 5 days per week, and
one staff grade 3.5 days per week). In addition
there are three consultant geriatrician-led ward
rounds per week. This model has previously
been described.
11 A fracture liaison service was
instituted in 2006. This consists of two fracture
liaison nurses (one full-time equivalent nurse)
who are responsible for assessing patients and
making speciﬁc treatment recommendations.
This involves requesting dual energy X-ray
absorptiometry (DEXA) scans and the correspon-
dence of results and treatment recommendations
to general practitioners. At present the fracture
liaison nurses only assess those inpatients who
are referred to the service.
Initial audits were performed independently at
both sites (100 patients at both sites) and included
all postmenopausal women who had sustained a
low-trauma fracture of neck of femur, distal wrist
or vertebra. Those who had sustained a pathologi-
cal fracture, a fracture as a result of high trauma, a
peri-prosthetic fracture or who did not survive to
discharge were excluded. We deﬁned a low-
trauma fracture as one sustained as a result of a
fall from standing or less.
For the purpose of comparison of data from
both sites, we included only women aged 75
years and over who had sustained a fractured
neck of femur. We excluded women aged under
75 years, those who had sustained a fracture at
another skeletal site, those who had sustained a
fracture as a result of high trauma, those who
had sustained a pathological fracture, those who
did not survive to discharge from hospital and
those with a peri-prosthetic fracture.
For site A, patients were identiﬁed using the
Emergency Department case-note coding system;
for site B, patients were identiﬁed using the Frac-
ture Liaison Service database. Each individual
audit only included small numbers of patients
aged under 75 years and non-comparable groups
of patients with distal wrist and vertebral fracture.
These subjects were excluded and in our compari-
sons we assessed all women from the initial audits
who were aged 75 years and over and who had
sustained a fractured neck of femur. This left a
group of 46 patients treated between January
2005 and December 2006 at site A and a group of
42 patients managed between January 2006 and
December 2007 at site B. We reviewed case-notes
and recorded patient demographics, enquiry into
risk factors, DEXA scan and treatment prescrip-
tion. General practice clerical staff were contacted
by telephone to review medication histories fol-
lowing hospital discharge and to identify
reasons for non-commencement of therapy.
Guidelines contained in the National Institute
for Clinical Excellence Technology Appraisal 87
(NICE TA 87)
12 were the standard for each audit.
The NICE TA 87
12 guidance for women aged 75
years and over who have sustained a fragility frac-
ture is that anti-resorptive treatment may be com-
menced without the requirement for a DEXA scan
to conﬁrm osteoporosis.
Statistical analysis (Chi-squared test and
Mann-Whitney U test) was performed using the
Statistical Package for the Social Sciences (SPSS
for Windows, version 16.0, Chicago, IL, USA).
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Both groups comprised elderly women aged 75
years and over. Table 1 details baseline character-
istics and Figure 1 illustrates the age distribution
of the groups from site A and site B.
Table 2 and Figure 2 illustrate the absolute fre-
quencies of the various treatment modalities at
both sites. At site A 28 of 46 subjects (60.9%)
were prescribed a bisphosphonate, strontium or
raloxifene with or without a calcium and vitamin
D supplement. Strontium (one patient at site A)
and raloxifene (one patient at site A) were pre-
scribed appropriately in women who had pre-
viously failed to tolerate a bisphosphonate. At
site B 38 of 42 subjects (90.5%) were prescribed a
bisphosphonate with or without a calcium and
vitamin D supplement. Anti-resorptive treatment
was commenced in 60.9% (site A) and 90.5%
(site B) of patients (difference 29.6%, p <0.001)
(Figure 3). Bisphosphonates were the most com-
monly prescribed anti-resorptive therapy at both
sites. At site A three patients and at site B one
patient received only calcium and vitamin D
supplementation. There was no documented
reason for non-commencement of bisphosphonate
therapy in these patients.
While at site B more patients were prescribed
anti-resorptive treatment, it was more common
for calcium and vitamin D supplementation to
be prescribed alongside anti-resorptive therapy
at site A. At site A 56.5% of patients and at site B
only 47.6% (P value 0.231) of patients were
treated with both an anti-resorptive agent and a
calcium and vitamin D prescription.
AtsitesAandB,0%and2%underwentaDEXA
scan, respectively. Documentation of enquiry into
risk factors was recorded in 7% (site A) and 83%
(site B) of cases (p<0.001) (Figure 4). In both
groups only four patients (sites A and B) had pre-
viously fractured a bone, and three patients at site
A and four at site B were on steroid therapy for a
concomitant condition. These values did not
show a statistically signiﬁcant difference between
the groups (Table 1).
Discussion
We compared osteoporosis secondary prevention
assessment and treatment in women aged 75
years and over managed for fractured neck of
femur in two fracture units utilizing different
models of service delivery. We demonstrated a
Table 1
Baseline characteristics of patient groups for sites A and B
Site A Site B P value
Cases (n)4 6 4 2
Median age (years) 84 84 0.445
Range 13 (75 – 88) 13 (75 – 88)
Standard deviation 3.55 3.61
Previous fracture (%) 8.7 9.5 0.827
Steroid use (%) 6.5 9.5 0.447
Figure 1
Distribution of fracture neck of femur by age at both sites
Table 2
Frequency of prescription of the various second-
ary preventative therapies and of no treatment at
sites A and B
Site A
(%)
Site B
(%)
P
value
Bisphosphonate alone 4 5 0.733
Bisphosphonate and
calcium
03 8 <0.001
Bisphosphonate and
calcium and vitamin D
52 48 0.572
Strontium and calcium
and vitamin D
2 0 0.155
Raloxifene and calcium
and vitamin D
2 0 0.155
Calcium alone 0 0
Calcium and vitamin D
alone
4 2 0.407
No treatment 36 7 <0.001
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3statistically signiﬁcant difference (29.6%, p <
0.001) in the rate of anti-resorptive prescription
between the two models with the enhanced frac-
ture liaison service model (site B) performing
more favourably. Of those receiving treatment,
prescriptions varied at both sites, with patients
at site A more likely to receive concomitant
prescription of calcium and vitamin D alongside
anti-resorptive treatment. More patients at site B
(fracture liaison service) were prescribed second-
ary preventative therapy, however not all were
prescribed calcium and vitamin D also. We also
demonstrated a difference in the rates of docu-
mentation of enquiry into osteoporosis risk
factors between the two models. In site B inpatient
notes had a clearly documented record of risk
factor data in 83% of cases, compared with 7% in
site A.
Our ﬁndings have a number of limitations and
are only applicable to postmenopausal women
aged 75 years and over whowere treated forafrac-
tured neck of femur. The initial audits at each site
included women who were postmenopausal and
aged under 75 years and also women who had
sustained a fragility fracture of distal wrist and
vertebra. The numbers of patients aged under 75
years included in the initial audits at each site
were too few to allow meaningful comparisons
to be drawn, and therefore these younger ladies
were excluded from our comparative audit. The
numbers of patients with a vertebral fracture
were also small and were excluded. At site B a
greater proportion of wrist fractures were
managed operatively than at site A. On further
inspection this included a signiﬁcant proportion
who were transferred from other units for man-
agement of their complex fractures. The wrist frac-
tures managed at site B were more complex than
those managed at site A and so we excluded
these from our comparative analysis. The subjects
included in the comparative analysis were from a
clearly deﬁned group, however after these with-
drawals the numbers involved are small.
Also the two sites utilized different methods
of case coding and it was necessary to use two
different systems to identify eligible patients.
The time period for case identiﬁcation was
different at each site, but did overlap. The
initial audits at each site were performed inde-
pendently and it was only after they had been
completed that the usefulness of comparing
results from both sites was identiﬁed. The
NICE guidelines were applicable during the
time periods for both audits. During the time
periods a much larger number of patients
could have been included in our initial audits,
however there were difﬁculties obtaining some
c a s e - n o t e s .W ea r en o ta b l et os t a t ed e ﬁ n i t i v e l y
if this affects the representative nature of the
sample from each site.
A strength of this study is that all information
identiﬁed from case-notes was veriﬁed by contact-
ing the patient’s primary care practice. We can
state that our documented treatment rates rep-
resent prescriptions which were continued after
discharge from hospital.
Figure 2
Absolute frequency of treatment modality for each site
Figure 3
Percentage of patients from site A and site B who were prescribed
anti-resorptive treatment
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4A Scottish study comparing a unit with a frac-
ture liaison service to one with an orthogeriatri-
cian model of care similar to that at site A
demonstrated higher rates of DEXA scanning
and anti-resorptive treatment (35.5% to 19.5%
post hip fracture) among patients managed in
the unit with a fracture liaison service.
13 These
ﬁgures are lower than for both sites that we
audited, however this study used different audit
standards and assessed patients aged over 50
years, whereas both audits that we have described
included patients aged 75 years and over.
The fracture liaison service has been demon-
strated in a previous Scottish audit to be a highly
effective model of care with 97% of patients
assessed for osteoporosis following a neck of
femur fracture.
14 Results obtained for site B were
not as impressive as those obtained in the Scottish
fracture liaison service. We feel this may be
explained by the different responsibilities of frac-
ture liaison nurses in the Scottish centre (where
they are responsible for case ﬁnding) and at site
B (where they are referred cases). The fracture
liaison service at site B is evolving and it is pro-
posed that the fracture liaison nurses will
assume responsibility for case identiﬁcation in
the future. It is hoped that this will improve prac-
tice in site B further.
We have demonstrated higher rates of anti-
resorptive treatment (90.5% at site B and 60.9%
at site A). Patients treated for fractured neck of
femur are usually hospitalized for at least a week
and we feel that as both units have similar ortho-
geriatric models of care, most patients will have
been assessed by an orthogeriatrician. While
both units have performed favourably we
suggest that the 29.6% difference in prescription
of an anti-resorptive agent with or without a
calcium and vitamin D supplement may be attrib-
uted to the additional presence of an enhanced
fracture liaison service at site B. However there
are almost certainly other differences between
the sites which we have failed to recognize.
At the site with a fracture liaison service (site B) a
larger number of patients received treatment,
however a signiﬁcant proportion of this group
(47%) were not prescribed a calcium and vitamin
D supplement alongside their anti-resorptive treat-
ment. The NICE TA 87
12 guidelines suggest that
calcium and vitamin D supplementation should
be considered unless the clinician is certain the
patient is calcium and vitamin D replete. If in our
analysis we had used the rate of concomitant pre-
scription of anti-resorptive and calcium and
vitamin D supplement as our outcome measure,
our outcome would be different. At site A 56.5%
of patients and at site B only 47.6% (P value 0.231)
o fp a t i e n t sw e r et r e a t e dw i t hb o t ha na n t i - r e s o r p t i v e
agent and a calcium and vitamin D prescription.
This may weaken our suggestion that treatment
was better at the unit with a fracture liaison service.
There was a difference in rates of enquiry into
risk factors (7% at site A and 83% at site B). It is
likely that in site A an enquiry into osteoporosis
risk factors was made, but not documented. As
the fracture liaison service evolves at site B, a pro
forma may be introduced, which would be likely
to result in higher rates of enquiry into risk
factors. We suggest that the rates of enquiry into
risk factors may not be quite as marked as we
have demonstrated. We suggest that it is likely
that if a larger sample was examined there may
also be more noticeable treatment beneﬁts.
We have demonstrated modest differences in
practice among women aged 75 years and over
with a fractured neck of femur in the sites with
and without a fracture liaison service. We feel
that both models have performed well in this
patient group, and compare favourably to a
reported 25% rate of treatment in women aged
75 years and over with a recorded previous fragi-
lity fracture in a community-based audit.
15 We
suggest that a fracture liaison service may be
more beneﬁcial in increasing osteoporosis assess-
ment and treatment rates in patients who receive
treatment for wrist, vertebral, proximal humerus
or ankle fracture. These patients may have more
Figure 4
Percentage of patients at each site in whom an enquiry into possible
risk factors for osteoporosis was document
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5to gain from appropriate secondary preventative
therapy. They may only be admitted to hospital
for a short period or may be managed solely on
an outpatient basis and are less likely to be
assessed by an orthogeriatrician. A fracture
liaison service may also show more beneﬁt
among patients who are not admitted to hospital.
Futurework should aim to examine the effects of a
fracture liaison service on the assessment and
treatment of all patients with lowtraumafractures.
Conclusions
The implementation of best practice guidelines in
the clinical setting often presents a logistic chal-
lenge and our audit allows two of the commonest
systems to be compared. Our audit ﬁndings
showed that both ward-based orthogeriatric care
and fracture liaison services can result in higher
levels of secondary prevention than noted in pre-
vious community studies. Our audit results
provide modest support for the view that the frac-
ture liaison service (combined with orthogeriatric
care) results in a higher rate of secondary preventa-
tive therapy than orthogeriatric care alone. We did
ﬁnd that in some cases calcium and vitamin D had
not been added to bisphosphonate therapy. Our
ﬁndings also support the view that ward-based
orthogeriatriccare isaneffective modelforsecond-
ary prevention of osteoporosis for female patients
aged 75 years and over who are admitted follow-
ing fractured neck of femur. We suggest that a frac-
ture liaison service may show additional beneﬁt in
patients who are not admitted to hospital. The
local choice of a model of service delivery is
likely to vary throughout the UK and Ireland, but
audits such as ours can help to inform service
planning. An accurate costing of the fracture
liaison service model is also required, and it is
likely that different models of care will be appro-
priate for different units.
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